Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Boronic Acid-based Enzyme Inhibitors: A Review of Recent Progress

Author(s): H. Fu, H. Fang, Jie Sun, H. Wang, A. Liu, J. Sun and Z. Wu

Volume 21 , Issue 28 , 2014

Page: [3271 - 3280] Pages: 10

DOI: 10.2174/0929867321666140601200803

Price: $65

Abstract

Since Bortezomib was approved by US FDA as the first drug to treat multiple myeloma, various boronic acid compounds have been developed as enzyme inhibitors. This paper reviewed the progress of boronic acid-based inhibitors against enzymes including proteasome, serine protease, HDACs and other enzymes in the past decade.

Keywords: Boronic acid, bortezomib, enzyme inhibitor, HDACs, proteasome inhibitor, serine protease.


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy